Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia | MicrobiomeTrials

← Back to trials

NCT06822790

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2025-04-09Est. Completion: 2028-07

Enrollment target: 869 participants

Locations

Research Site 21, Bakersfield, California, United States
Research Site 9, Beverly Hills, California, United States
Research Site 11, Canoga Park, California, United States
Research Site 40, Garden Grove, California, United States
Research Site 235, Huntington Beach, California, United States
Research Site 236, Lake Forest, California, United States
Research Site 39, Lincoln, California, United States
Research Site 34, Oxnard, California, United States
Research Site 229, Palm Springs, California, United States
Research Site 275, Redding, California, United States
Research Site 155, Fort Lauderdale, Florida, United States
Research Site 14, Hialeah, Florida, United States
Research Site 154, Miami, Florida, United States
Research Site 1, Miami Lakes, Florida, United States
Research Site 162, Mt. Dora, Florida, United States
Research Site 42, Mt. Dora, Florida, United States
Research Site 38, North Miami, Florida, United States

Other microbiome trials you might be interested in

PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70.Recruiting

Multiple MyelomaComplication

This is a prospective, multicentre, phase III, randomised, controlled intervention study. Two groups of patients with e…

Épagny, FranceEst. completion Jun 14, 2028

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute PancreatitisPhase 3Recruiting

Severe Hypertriglyceridemia

This study will evaluate the efficacy and safety of plozasiran in approximately 288 adult participants with severe hyper…

Los Angeles, United StatesEst. completion Mar 2029

Study of the Efficacy and Safety of Goflikicept and Olokizumab as the Second-line Therapy in Patients With Still's Disease

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.